EAPC Premium Access

Young Investigators Award Secondary Prevention and Rehabilitation

Event: ESC Preventive Cardiology 2021
Topic: Risk Factors and Prevention
Session type: Award Sessions
Date: 17 April 2021
Time: 08:50 - 09:35

Congress Session

Become an EAPC member to access this resource

Become a member

Already a member? Sign in

6 presentations in this session

Physical activity and sedentary behaviour in cardiovascular disease patients during the COVID-19 lockdown in the Netherlands; a longitudinal cohort study

Speaker: Mr B. van Bakel (Nijmegen, NL)

Lifestyle management and compliance in coronary patients: The gender gap. Results from the ESC EORP EUROASPIRE V survey

Speaker: Mr P. Vynckier (Ghent, BE)

Cardiac rehabilitation and all-cause mortality in patients with heart failure: A retrospective cohort study

Speaker: Doctor B. Buckley (Liverpool, GB)

Optimal strategy for antiplatelet therapy after coronary drug-eluting stent implantation in high-risk "TWILIGHT-like" patients with diabetes mellitus

Speaker: Doctor H. Wang (Beijing, CN)

Effectiveness of cardiac telerehabilitation with relapse prevention compared to centre-based cardiac rehabilitation: results from the SmartCare-CAD randomised controlled trial

Speaker: Mr R. Brouwers (Veldhoven, NL)

Low skeletal muscle density combined with muscle dysfunction predicts adverse events after adult cardiovascular surgery

Speaker: Mr M. Yamashita (Sagamihara, JP)

6 speakers from this session

Mr Bram van Bakel

Radboud University Medical Centre, Nijmegen (Netherlands (The))
0 follower

Mr Pieter Vynckier

Ghent University, Ghent (Belgium)
0 follower

Doctor Ben Buckley

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

Doctor Haoyu Wang

Fuwai Hospital, CAMS and PUMC, Beijing (China)
0 follower

Mr Rutger Brouwers

Maxima Medical Centre, Veldhoven (Netherlands (The))
5 presentations
0 follower

Mr Masashi Yamashita

Kitasato University Graduate School of Medical Sciences, Sagamihara (Japan)
0 follower

This platform is supported by

logo Novo Nordisk